Therapeutic Proteins and Oral Vaccines Market Size, Share & Trends Analysis Report By Drug Class, By Distribution Channel, By Application (Oncology, Hematology, Immunology, Endocrinology, Infectious Disease, Cardiovascular Disease, Other Applications), By Region, And By Segment Forecasts, 2024-2031

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Therapeutic Proteins and Oral Vaccines Market Snapshot

Chapter 4. Global Therapeutic Proteins and Oral Vaccines Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Drug Class, Estimates & Trend Analysis

5.1. By Drug Class, & Market Share, 2019 & 2031

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Drug Class:

5.2.1. Therapeutic Proteins

5.2.1.1.  Growth Factors

5.2.1.2.  Fusion Proteins

5.2.1.3.  Monoclonal Antibodies

5.2.1.4.  Hormones

5.2.1.5.  Coagulation Factors

5.2.1.6.  Other Therapeutic Proteins

5.2.2. Oral Vaccines

5.2.2.1.  Live Attenuated Vaccine

5.2.2.2.  Inactivated Vaccine

5.2.2.3.  Recombinant Vaccine

5.2.2.4.  Other Oral Vaccines

Chapter 6. Market Segmentation 1: By Distribution Channels Estimates & Trend Analysis

6.1. By Distribution Channels & Market Share, 2019 & 2031

6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Distribution Channels:

6.2.1. Hospital Pharmacies

6.2.2. Retail Pharmacies

6.2.3. Online Pharmacies

Chapter 7. Market Segmentation 1: By Applications Estimates & Trend Analysis

7.1. By Applications & Market Share, 2019 & 2031

7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following By Applications:

7.2.1. Oncology

7.2.2. Hematology

7.2.3. Immunology

7.2.4. Endocrinology

7.2.5. Infectious Disease

7.2.6. Cardiovascular Disease

7.2.7. Other Applications

Chapter 8. Therapeutic Proteins and Oral Vaccines Market Segmentation 3: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Drug Class, 2024-2031

8.1.2. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Distribution Channels, 2024-2031

8.1.3. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts By Applications, 2024-2031

8.1.4. North America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) estimates and forecasts by country, 2024-2031

8.2. Europe

8.2.1. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, 2024-2031

8.2.2. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, 2024-2031

8.2.3. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, 2024-2031

8.2.4. Europe Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, 2024-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, 2024-2031

8.3.2. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, 2024-2031

8.3.3. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, 2024-2031

8.3.4. Asia Pacific Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, 2024-2031

8.4. Latin America

8.4.1. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, (US$ Million) 2024-2031

8.4.2. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, (US$ Million) 2024-2031

8.4.3. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, (US$ Million) 2024-2031

8.4.4. Latin America Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, (US$ Million) 2024-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Drug Class, (US$ Million) 2024-2031

8.5.2. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Distribution Channels, (US$ Million) 2024-2031

8.5.3. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) By Applications, (US$ Million) 2024-2031

8.5.4. Middle East & Africa Therapeutic Proteins and Oral Vaccines Market revenue (US$ Million) by country, (US$ Million) 2024-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Abbott Laboratories

9.2.2. Amgen, Inc.

9.2.3. Biogen, Inc.

9.2.4. Eily, Lilly, and Company

9.2.5. F. Hoffmann-La Roche

9.2.6. Johnson and Johnson

9.2.7. Merck & Co.

9.2.8. Novo Nordisk

9.2.9. Pfizer, Inc.

9.2.10. Sanofi S.A.

9.2.11. Serum Institute of India Pvt. Ltd.

9.2.12. Emergent Biosolutions Inc.

9.2.13. TransAlgae

9.2.14. MigVax Ltd

9.2.15. Lumen Bioscience, Inc.

9.2.16. Neurelis, Inc.

9.2.17. Other Prominent Player

Global Therapeutic Proteins and Oral Vaccines Market Segmentation

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Drug Class

• Therapeutic Proteins
• Growth Factors
• Fusion Proteins
• Monoclonal Antibodies
• Hormones
• Coagulation Factors
• Other Therapeutic Proteins
• Oral Vaccines
• Live Attenuated Vaccine
• Inactivated Vaccine
• Recombinant Vaccine
• Other Oral Vaccines

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Distribution Channels

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Applications

• Oncology
• Hematology
• Immunology
• Endocrinology
• Infectious Disease
• Cardiovascular Disease
• Other Applications

Global Therapeutic Proteins and Oral Vaccines Market Size (Value US$ Mn) & Forecasts and Trend Analyses, Based on Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

North America Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country,

• U.S.
• Canada

Europe Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country,

• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 

• India
• China
• Japan
• South Korea
• Australia & New Zealand

Latin America Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 

• Brazil
• Mexico
• Rest of Latin America

Middle East & Africa Therapeutic Proteins and Oral Vaccines Market Revenue (US$ Million) By Country, 

• GCC Countries
• South Africa
• Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

• Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
• External and internal proprietary databases, regulatory databases, and relevant patent analysis
• Statistical databases, National government documents, and market reports
• Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

• Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
• Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
• Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
• End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.